A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification
- PMID: 16151858
- DOI: 10.1007/s00439-005-0026-8
A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification
Abstract
Hyperphosphatemic Familial Tumoral Calcinosis (HFTC; MIM211900) is a rare autosomal recessive disorder characterized by the progressive deposition of calcified masses in cutaneous and subcutaneous tissues, associated with elevated circulating levels of phosphate. The disease was initially found to result from mutations in GALNT3 encoding a glycosyltransferase. However, more recently, the S71G missense mutation in FGF23, encoding a potent phosphaturic protein, was identified in two families. In the present report, we describe a second mutation in FGF23 underlying a severe case displaying calcifications of cutaneous and numerous extracutaneous tissues. The mutation (M96T) was found to affect a highly conserved methionine residue at position 96 of the protein. These observations illustrate the extent of genetic and phenotypic heterogeneity in HFTC.
Similar articles
-
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.Hum Mol Genet. 2005 Feb 1;14(3):385-90. doi: 10.1093/hmg/ddi034. Epub 2004 Dec 8. Hum Mol Genet. 2005. PMID: 15590700
-
The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.J Clin Endocrinol Metab. 2006 Oct;91(10):4037-42. doi: 10.1210/jc.2006-0305. Epub 2006 Jul 25. J Clin Endocrinol Metab. 2006. PMID: 16868048
-
Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature.BMC Genet. 2014 Sep 24;15:98. doi: 10.1186/s12863-014-0098-3. BMC Genet. 2014. PMID: 25249269 Free PMC article. Review.
-
Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred.J Hum Genet. 2006;51(5):487-490. doi: 10.1007/s10038-006-0377-6. Epub 2006 Mar 10. J Hum Genet. 2006. PMID: 16528452
-
Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.Osteoporos Int. 2018 Sep;29(9):1987-2009. doi: 10.1007/s00198-018-4574-x. Epub 2018 Jun 20. Osteoporos Int. 2018. PMID: 29923062 Review.
Cited by
-
A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.J Bone Miner Res. 2012 Feb;27(2):453-60. doi: 10.1002/jbmr.544. J Bone Miner Res. 2012. PMID: 22006791 Free PMC article.
-
Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy.Front Endocrinol (Lausanne). 2015 Sep 29;6:154. doi: 10.3389/fendo.2015.00154. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26483756 Free PMC article. Review.
-
The FGF metabolic axis.Front Med. 2019 Oct;13(5):511-530. doi: 10.1007/s11684-019-0711-y. Epub 2019 Sep 7. Front Med. 2019. PMID: 31495905 Free PMC article. Review.
-
GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity.Biochim Biophys Acta. 2009 Jan;1792(1):61-7. doi: 10.1016/j.bbadis.2008.09.016. Epub 2008 Oct 11. Biochim Biophys Acta. 2009. PMID: 18976705 Free PMC article.
-
Galnt3 deficiency disrupts acrosome formation and leads to oligoasthenoteratozoospermia.Histochem Cell Biol. 2013 Feb;139(2):339-54. doi: 10.1007/s00418-012-1031-3. Epub 2012 Sep 28. Histochem Cell Biol. 2013. PMID: 23052838
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases